文献速递心脏核医学

肝移植候选者的定量心肌灌注:代谢不良的咖啡因抑制血管扩张负荷

Quantitative myocardial perfusion in liver transplantation candidates: Poorly metabolized caffeine inhibition of vasodilatory stress.
PubMed 文献 · J Nucl Cardiol · 2024-05-16

该研究纳入114例连续肝移植候选者行心脏静息/负荷PET,因咖啡因清除延迟,将双嘧达莫改为多巴酚丁胺负荷。肝移植候选者血咖啡因可检出率在戒咖啡因2、5、7天后分别为63.3%、36.7%、33.3%。双嘧达莫负荷下无咖啡因时冠脉血流储备高于有咖啡因时,但低于多巴酚丁胺负荷;肝移植候选者冠脉血流储备低于非肝移植对照组。

要点

  • 肝移植候选者咖啡因清除延迟,戒咖啡因7天后仍有33.3%可检出。
  • 双嘧达莫负荷下无咖啡因时冠脉血流储备高于有咖啡因时,但低于多巴酚丁胺负荷。
  • 肝移植候选者冠脉血流储备低于非肝移植对照组。

核心结论

  • 肝移植候选者行负荷PET心肌灌注显像时血咖啡因可检出率极高,导致双嘧达莫负荷下冠脉血流储备降低,而多巴酚丁胺负荷下较高。
  • 肝移植候选者咖啡因清除延迟,使得多巴酚丁胺成为该人群首选的负荷药物。

研究设计与样本

  • 连续纳入114例肝移植候选者行心脏静息/负荷PET,因5天戒咖啡因后血咖啡因可检出率仍高,将初始使用的双嘧达莫(n=41)改为多巴酚丁胺(n=73)。
  • 评估绝对血流、冠脉血流储备(CFR)、可检出血液咖啡因与反映肝衰竭严重程度的终末期肝病模型(MELD)评分的关联。
  • 将肝移植候选者的冠脉血流数据与非肝移植对照组(双嘧达莫组n=102,多巴酚丁胺组n=29)比较。

主要发现

  • 戒咖啡因2天、5天和7天后,血咖啡因可检出率分别为63.3%、36.7%和33.3%。
  • MELD评分与可检出咖啡因相关(比值比1.18,P<0.001)。
  • 双嘧达莫负荷下,无咖啡因时CFR为2.22±0.80,高于有咖啡因时的1.55±0.37(P=0.048)。
  • 双嘧达莫负荷下CFR为2.22±0.80,低于多巴酚丁胺负荷的2.82±1.02(P=0.026)。
  • 中介分析提示,双嘧达莫组CFR与MELD评分的主要关联源于咖啡因损害的CFR及肝衰竭/咖啡因交互作用。

临床怎么用

  • 作者认为,肝移植候选者咖啡因清除延迟,使得多巴酚丁胺成为该人群首选的负荷药物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on cardiac positron emission tomography (PET) in liver transplantation (LT) candidates are limited with no prior study accounting for poorly metabolized caffeine reducing stress perfusion. METHOD: Consecutive LT candidates (n = 114) undergoing cardiac rest/stress PET were instructed to abstain from caffeine for 2 days extended to 5 and 7 days. Due to persistently high prevalence of measurable blood caffeine after 5-day caffeine abstinence, dipyridamole (n = 41) initially used was changed to dobutamine (n = 73). Associations of absolute flow, coronary flow reserve (CFR), detectable blood caffeine, and Modified End-Stage Liver Disease (MELD) score for liver failure severity were evaluated. Coronary flow data of LT candidates were compared to non-LT control group (n = 102 for dipyridamole, n = 29 for dobutamine). RESULTS: Prevalence of patients with detectable blood caffeine was 63.3%, 36.7% and 33.3% after 2-, 5- and 7-day of caffeine abstinence, respectively. MELD score was associated with detectable caffeine (odd ratio 1.18,P < 0.001). CFR was higher during dipyridamole stress without-caffeine versus with-caffeine (2.22 ± 0.80 vs 1.55 ± 0.37,P = 0.048) but lower than dobutamine stress (2.22 ± 0.80 vs 2.82 ± 1.02,P = 0.026). Mediation analysis suggested that the dominant association between CFR and MELD score in dipyridamole group derived from caffeine-impaired CFR and liver failure/caffeine interaction. CFR in LT candidates was lower than non-LT control population in both dipyridamole and dobutamine group. CONCLUSION: We demonstrate exceptionally high prevalence of detectable blood caffeine in LT candidates undergoing stress PET myocardial perfusion imaging resulting in reduced CFR with dipyridamole compared to dobutamine. The delayed caffeine clearance in LT candidates makes dobutamine a preferred stress agent in this population.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Kitkungvan D, Johnson NP, Roby AE, et al. Quantitative myocardial perfusion in liver transplantation candidates: Poorly metabolized caffeine inhibition of vasodilatory stress. J Nucl Cardiol. 2024. PMID: 38761831. doi:10.1016/j.nuclcard.2024.101884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。